Myeloid cell-specific Beta2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1

By afschroeder • February 17, 2026

Nayak TK, Bajpai A, Patwa V, Carter RL, Enjamuri N, Gao E, Rajan S, Xiang YK, Tilley DG. Myeloid cell-specific β2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1. Theranostics. 2026 Jan 14;16(8):3959-3976. doi: 10.7150/thno.123651. PMID: 41695468; PMCID: PMC12905670.

Tags: Cardiology/Epi, Publications

Procedural and Functional Outcomes After Computer Assisted Vacuum Thrombectomy With the 16F Catheter System for Treatment of Pulmonary Embolism: A Subanalysis of the STRIKE-PE Study

Moriarty JM, Schiro BJ, Weinberg I, Dohad SY, Davis HC, Shavelle DM, Chrysant GS, Perkowski PE, Muck PE, Bishay VL, Holden A, West FM, Scheidt[...]

A Special Muscle Fiber Surviving After Septal Line Ablation of Mitral-Isthmus Dependent Atrial Flutter

Yamada T, Akrawinthawong K, Miyazaki Y, Mori S. A Special Muscle Fiber Surviving After Septal Line Ablation of Mitral-Isthmus Dependent Atrial Flutter. J Arrhythm. 2026[...]

Striking Surge in Lung Cancer Incidence in Children of Early Life

Zong NC, Johal J, Liu H, Cai H. Striking Surge in Lung Cancer Incidence in Children of Early Life. J Respir Biol Transl Med. 2026;3(2):10004.[...]